FDG-PET/CT in the Diagnosis and Monitoring of Psoriatic Arthritis
N/A
18 Years
80 Years
18 Years
80 Years
Open (Enrolling)
Both
Psoriatic Arthritis
Both
Psoriatic Arthritis
Trial Information
FDG-PET/CT in the Diagnosis and Monitoring of Psoriatic Arthritis
Inclusion Criteria:
- Age 18-80,
- active psoriatic arthritis (joint or enthesis inflammation)
Exclusion Criteria:
- Diabetes,
- pregnant,
- no active PsA
Type of Study:
Observational
Study Design:
Observational Model: Case-Only, Time Perspective: Cross-Sectional
Principal Investigator
Alexis R Ogdie, MD, MSCE
Investigator Role:
Principal Investigator
Investigator Affiliation:
University of Pennsylvania
Authority:
United States: Food and Drug Administration
Study ID:
815253
NCT ID:
NCT01654198
Start Date:
July 2012
Completion Date:
May 2013
Related Keywords:
- Psoriatic Arthritis
- Arthritis
- Arthritis, Psoriatic
Name | Location |
|---|---|
| University of Pennsylvania Division of Rheumatology | Philadelphia, Pennsylvania 19104 |
